US Drug Recall Register
Class III · Low risk Terminated Initiated Nov 12, 2021 (5 years ago)

Antihistamine & Nasal Decongestant

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed dissolution specifications

What was recalled

Antihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy & Congestion, 12 Hour, 30 Tablets, Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152, www.rugbylaboratories.com. NDC 0638-1242-07.

Recalling firm
Dr. Reddy's Laboratories, Inc.
NDC code
0638-1242-07
Origin
NJ, United States
Initiated by
N/A
FDA recall number
D-0271-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fexofenadine recalls

See all
Class III · Low risk Ongoing

Fexofenadine Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries INC NDC 66336-561-30 D-0654-2026
Class II · Moderate risk Completed

Fexofenadine Hydrochloride Tablets

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 51660-998-30 D-0273-2024
Class II · Moderate risk Terminated

Allergy Relief

Reason Failed Impurities/Degradation Specifications

L. Perrigo Company NDC 36800-691-39 D-0912-2023
Class II · Moderate risk Terminated

Picnic

Reason Failed Impurities/Degradation Specifications

L. Perrigo Company D-0911-2023
Class II · Moderate risk Terminated

allergy relief

Reason Failed Impurities/Degradation Specifications

L. Perrigo Company NDC 11673-617-22 D-0910-2023